| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 104.24B | 97.85B | 112.90B | 120.80B | 101.12B | 77.51B |
| Gross Profit | 28.71B | 24.81B | 28.74B | 31.09B | 25.93B | 17.36B |
| EBITDA | 15.73B | 13.32B | 16.83B | 19.34B | 16.51B | 10.05B |
| Net Income | 7.39B | 5.64B | 10.48B | 11.41B | 9.02B | 3.94B |
Balance Sheet | ||||||
| Total Assets | 159.73B | 145.63B | 150.69B | 143.87B | 128.67B | 113.96B |
| Cash, Cash Equivalents and Short-Term Investments | 29.43B | 28.90B | 26.69B | 20.55B | 18.78B | 14.85B |
| Total Debt | 5.76B | 7.28B | 14.53B | 20.15B | 20.25B | 19.11B |
| Total Liabilities | 37.08B | 32.28B | 40.31B | 50.65B | 48.01B | 43.57B |
| Stockholders Equity | 122.65B | 113.35B | 110.36B | 93.21B | 80.65B | 70.38B |
Cash Flow | ||||||
| Free Cash Flow | 11.70B | 13.12B | 15.72B | 5.08B | 4.96B | 1.95B |
| Operating Cash Flow | 13.40B | 15.79B | 21.45B | 8.26B | 8.23B | 4.96B |
| Investing Cash Flow | -5.31B | -3.73B | -6.47B | -4.42B | -4.83B | -4.29B |
| Financing Cash Flow | -8.39B | -9.69B | -10.67B | -2.67B | -622.00M | 10.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥161.71B | 16.57 | ― | 1.53% | 3.37% | 21.35% | |
72 Outperform | ¥50.94B | 12.37 | ― | 0.91% | 5.28% | 18.38% | |
72 Outperform | $1.15T | 35.76 | 8.39% | 1.49% | -2.18% | 30.16% | |
71 Outperform | €10.81T | 21.58 | 9.29% | 1.19% | 4.62% | 40.65% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥1.55T | 19.95 | 12.05% | 1.50% | 5.44% | -5.19% | |
59 Neutral | ¥48.95B | -60.12 | ― | 5.01% | -32.74% | -117.06% |